Up to 65% of patients with multiple sclerosis (MS) experience cognitive dysfunction. Diminution of mental capacity has a pervasive and profound impact on their quality of life. Subtle changes in white matter predict cognitive changes in these patients but how this disrupts brain function remains unclear. Development of effective therapeutics to restore normal cognition hinges on elucidating these functional changes. The investigators seek to uncover the patho-physiological basis for cognitive decline in MS. The investigators hypothesize that cognitive decline originates from disrupted gamma oscillations and that gamma oscillations are disrupted by molecular changes triggered by demyelination.
Study Type
OBSERVATIONAL
Enrollment
20
Hospital for Sick Children
Toronto, Ontario, Canada
Neuronal responses during simple and choice reaction time tasks
Video-based eye tracking in the MEG
Time frame: 60 minutes
MRI scans of the brain, including Diffusion Tensor Imagine (DTI)
Time frame: 90 minutes
Neurocognitive Testing
Penn Computerized Neurocognitive Battery
Time frame: 90 minutes
Neurological Exam - Standard physical exam performed by the neurologist to determine the Expanded Disability Status Scale (EDSS) score.
Time frame: 20 minutes
Clinical Interview
Series of questions about the participant's demographic and clinical information including, current and past health, family history, and medications.
Time frame: 10 minutes
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.